The effects of two chemically different interferon inducers on the suppression of atherosclerosis were studied in rabbits fed an atherogenic chow diet. One group (10 rabbits per group) was fed normal rabbit chow, and three groups were fed an atherogenic chow. One of the latter groups received the atherogenic feeding alone; the other two were treated with either polyinosinic-polycytidylic acid (poly I:C) or 2-amino-5-bromo-6-phenyl-4pyrimidinone (ABPP). Neither of the drugs reduced significantly the hypercholesterolemia induced by the feeding. However, both poly I:C and ABPP treatment significantly reduced the percent area of the aortic intimal surface lesions, stained for lipid with Sudan IV, compared with that in untreated rabbits fed atherogenic chow.
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The pathogenesis of atherosclerosis IS charactenzed by the proliferation of cells in the intima and the focal accumulation of lipid and connective tissue (1). Although elevated serum cholesterol IS considered to be a major factor in the development of the disease, several effective antlatherogemc agents that are not aimed at lowering serum cholesterol have been descnbed Most of these, such as rufedipme (2) , diphosphonates (3) and lanthanum (4) , act by mhibinng the calcium overload m artenal cells of cholesterol-fed rabbits However, suppression of expenmental atherosclerosis m rabbits was also achieved With an antiprohferative drug, colchicme (5) , and ItS derivative Dernecolcme (Colcermd) (3) Inter-Microscopic sections of typical aortic plaques showed that both drug treatments significantly reduced the size and number of intimal lipid deposits compared with those observed in the aortas of untreated animals. Chemical analysis for cholesterol and collagen content revealed that interferon-inducing agents significantly reduced cholesterol deposits in the aorta, with little effect on fibrous protein deposition. The results indicate that two unrelated interferon-inducing drugs suppressed atherogenesis without reducing serum cholesterol and low density lipoprotein levels. Whether the protection against atherosclerosis is exerted by endogenous interferon production remains to be determined. feron IS being used to suppress abnormal cellular prohferation in the treatment of mahgnant diseases (6) . Hypothesizing that the atherogenic mechanism might be Similar to neoplastic activity, we mitiated studies to examine the possibility of using interferon or ItS inducers as antiatherogemc agents
Interferons are glycoprotems produced by many types of cells m response to induction by a chemically diverse group of agents, and exhibit a variety of antiviral, anticancer and immunomodulatory activities (7) We report on treatment with two chemically unrelated interferon inducers a high molecular weight synthetic polynucleotide, polymosmicpolycyndyhc acid (poly I C) (8), and a low molecular weight pynnudine denvative, 2-ammo-5-bromo-6-phenyl-4(3H)pynrrudinone (ABPP) (9) , which suppress aortic cellular proliferation and lipid deposition in the cholesterol-fed rabbit, Without reducmg the dietary-mduced hypercholesterolemia Methods Animals and diet. Forty young adult male New Zealand white rabbits weighing 2 to 2 5 kg were assigned randomly to four groups of 10 rabbits each One group received a diet of Punna rabbit chow (normal diet) The other three groups received a fibrogemc-atherogemc diet (10) Experimental procedure. One group of 10 rabbits was fed the atherogemc diet without drug treatment (no drug group) The second group was treated with poly I.C (P-L Biocherrucals, Inc) once a week by Intravenous mjection (100 JLg/kg body weight) Into the marginal ear vein The synthetic double-stranded nbonucleic acid (RNA) (poly I C) was reconstituted at a concentration of 1 mg/ml In stenle phosphate-buffered sahne solution, pH 7 0 (0 006 M sodium phosphate, 0 15 M sodium chlonde) and allowed to reanneal by heating In a 50°C water bath until dissolved and then standing at room temperature to cool The third group was treated WithABPP (The Upjohn Company) once a week by mtrapentoneal Injection in doses of 200 mg/kg body weight ThIS drug was adrmrustered as a suspension In 5 ml stenle phosphate-buffered sahne solution USIng a twosynnge technique to generate and dehver the suspension Body weight and food consumption were recorded and fastmg blood samples were collected at the begmmng of the study and after 4 and 8 weeks of the diet treatment for the deterrrunation of total cholesterol by the Techmcon AAII automated Liebermann-Burchard method as descnbed m the Lipid Research Climes Program Manual (11) Lipoproteins were separated from serum by sequential ultracentnfugation (12). Serum interferon titers were determined by a vesicular stomatitis VIral plaque reduction assay on pnmary rabbit kidney cells (13) Postmortem studies. The rabbits were killed after 9 weeks and the whole aorta from the aortic valve to the iliac bifurcation was removed from each ammal. The aorta was opened longitudinally along ItS antenor wall, and the advenuna and adhenng adipose tissue were removed The vessel was fixed and stained grossly WIth Sudan IV (14) to visualize the hpid-nch atherosclerotic lesions After tracing on an overlaid clear plastic sheet, the aortic surface area and ItS hpid-stammg lesions were quantitated by an electromc graphics calculator (model 1223, Numomcs Corp ) Before stammg, small samples of aortic tissue were taken from three areas of each aorta. proximal to the left subclavian artery, mcluding the fifth Intercostal artenes, and distal to the ongm of the celiac trunk The sample from the tho-raCIC aorta was freeze-sectioned and stained With 011 red 0 for neutral hpid The other two samples of aortic tissue were embedded In paraffin, sectioned and stamed routinely With hematoxyhn-eosm, Masson's-tnchrome stain for collagen and Verhoeff-Van Giesen' s stain for elastin Sections from three areas of each paraffin block were used to quantitate lesion areas WIth a ZeISS VIdeo-Plan morphometnc analysis system ThIS analysis was performed bhndly to avoid subjectrve bias
Assays. Biochemical analysis of the total cholesterol content of the whole aorta was performed on duplicate aliquots of the total hpid extract (15) of the freeze-dned tissue Total aortic collagen content was determined by measunng the hydroxyproline content in duphcate USIng a colonmetnc method (16) The statistical significance of intergroup differences was determined by one-way analysis of vanance USIng the Student-Newman-Keuls procedure for pair-wise compansons (17) Results Serum lipids. There were no significant differences In the average food consumption and weight gam between the normal control group and the expenmental groups of rabbits In the rabbits fed the atherogemc diet, the concentration of total serum cholesterol increased from the normal levels to atherogemc levels whether or not mterferon-mducmg drugs were admmistered. The mean total serum cholesterol values (mg/IOO ml) for each group after 8 weeks of feeding were 43 ± 15 (mean ± standard deviation) m the normal diet group, 3,270 ± 873 m the untreated cholesterol-fed group and 2,709 ± 970 and 2,580 ± 899 in the cholesterol-fed groups treated With poly I C and ABPP, respectively ( Fig  1) The elevated serum cholesterol was due to elevated levels of cholesterol In very low density, Intermediate density and low density lipoprotein fractions Increases m serum tnglycende levels In the rabbits fed the atherogemc diet were smaller than those of serum cholesterol and were confined to very low and Intermediate density hpoprotem fractions There was no significant Increase In low density hpoprotem tnglycende content Interferon levels. Serum Interferon levels (3 hours after mjection) averaged 351 ± 29 umts/ml in rabbits treated WIth poly I C for 8 weeks compared WIth an average of 698 ± 28 umts/ml after the first Injection ThIS result indicated (FIg 3B) exhibited a markedly raised Intima With large prohferations of lipid-laden "foam" cells and some derangement of the mtimal-medial elastin layers In rabbits treated WIth either of the two interferon mducers (Fig 3C and D) , the lesions consisted of fewer layers of mnmal foam cells overlying an otherwise normal artenal wall Morphometric analysts of the lesion area as a percent of the total artenal wall area (mtima plus media) and determmation of the frequency distribution of the lesion size (Table 2 ) supported the findings of the gross morphologic and biochemical studies In both the poly I.C-and ABPPtreated groups of rabbits, the lesion area as a percent of the total vessel wall area was significantly less compared WIth that of untreated rabbits recervmg the atherogemc diet Frequency distrtbution analysis of lesion size revealed that both drug-treated groups had sigmficantly fewer large lesions (> 20% of total vessel area) m comparable areas of aorta than did the nontreated atherosclerotic control group .' 37±15% 20±9%* 19±13'/'* The use of mterferon-mducmg agents circumvents many of the hrmtatrons inherent m the production and rsolation of species-specific interferons In tlus study, we used two chemically dissmnlar inducers poly I C, a synthetic doublestranded RNA well known to be a potent inducer of rabbit interferon (8) , and a newly developed low molecular weight pynrrudme denvatrve, ABPP (9) , which induces high levels of serum interferon III several different species (18) The data presented in this report mdicate that both of these drugs were effective m suppressing the prohferation of hpid-Iaden foam cells and cholesterol deposits in aortic atherosclerotic plaques m rabbits SUPPRESSION OF EXPERIMENTAL ATHEROSCLEROSIS JACC Vol. .. 
Antuuherogenic Mechanisms of Interferon Inducers
Suppression of initiation or suppression of atherogenesis? The response to injury hypoth esis of atherogenesis ( I) suggests that endoth elial injury may lead to desquamatron , platelet adherence , aggregation and release of platelet constItuent s followed by prohferation of cells In the artenal mtim a The sources of imtial injury may Include chrome hypercholesterolerrua as well as immunol ogic , hemodynamic , mecharncal and chemical factors The monoclonal hypoth esis of athero genesis (19) maintains that, like benign smooth muscle tumors of the uterus, the prohferating cells of atherosclerotIc plaques may denve from monoclon al growth of vascular smooth muscle cells It IS not possible to determine from the present data whether the Interferon inducers are acting to suppress the minanon or the progression of the prohferanve phase of atherogenesis Effect on plasma cholesterol and lipoprotein. The adrmrustran on of human leukocyte Interferon has been reported to have profound effect s on the metabolism of plasma hpoprotems In human subjects (20) , lowenn g the plasma level of tot al cho les terol. very lo w densit y Irpoprotein cholesterol and apohpoprotem A-I However. the suppression of aornc atherosclero sis observed In our study does not appear to have been achieved by reduction of the expenmentall y Induced hypercholesterolemia Hypertension also IS a powerful atherogenic factor and Interferon and ItS inducers are known to cause transient hypotension and pyrexia after mjection (6.7) Although blood pressure and temperature were not monitored In this study, It IS unlikely that a blood pressure-lowenng effect IS an Important contn butmg mechanism because the mjections of the Interferon Inducers were spaced at weekly Intervals Anoth er pOSSIbIlIty IS that the drugs Interfere WIth the binding and uptake of cholesterol-nch lipoproteins However , under condmons of elevated serum cholesterol, the express ion of high affinity. low density lipoprotem receptors on the surface of normal endothehal and smooth muscle cells would be suppressed and thus any possible drug Interference would be negligibl e In addition, unpublished results from our laboratory indicate that interferon has no effect on the uptake of norm al or modified low density hpoprotem by monocyte-deri ved macroph ages Suppression of intimal cellular proliferation. The data strongly suggest that the rnechamsm of the present approach to reduce rabbit aortic atherosclerosis IS related to suppression of innmal cellul ar proli feration by endogenous interferon Clearly, the pOSSIbIlIty that suppression of the atherosclerosis observed In this study may be mediated by mterferon-rndependent mechanisms cannot be ruled out at this time Indeed . ABPP has been shown to enhance natural killer cells. cytotox ic macrophag es and antibody production (2 1), while poly 1 C has an adjuvant effect on Immunolo gic reacnvity (22) Wheth er this atheroscl erosis suppression can be attnbuted directly to Interferon IS being mvestigated In our laboratory by studies employmg punfied rabbit Interferon
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